» Download Public Reports
6 reports
- Company report
- November 2012
- 11 pages
... Adult source of cell to be used clinically has a generally weak therapeutic signal in many of the reported studies and trials. As the field matures, companies, researches, regulators, and clinicians ...
March 2011
... Driven by the increase in the company S stock price. Immunocellular therapeutics, ltd. Chief executive officer manish singh commented, We are pleased by the progress in our phase ii clinical trial ...
March 2011
... And licence to safinamide covering global rights excluding japan and other key asian territories Completion of the phase iii development programme for safinamide as an add-on therapy for parkinson ...
March 2011
... Increasing uptake of benlysta, uloric, krystexxa, and the launch of oral tofacitinib to spur growth. The report provides insights into the rheumatology therapeutics market forecasts until 2018 and examines ...
» Purchase Premium Reports
(From $ 1 500 - $ 3 500)
About 400 reports
- $ 3 500
- Industry report
- April 2013
- by GBI Research
ADHD Therapeutics Market to 2018 - New Diagnostic Parameters for Adult ADHD Offer Hope for Higher Rates of Treatment Summary GBI Research, the leading business intelligence provider, has released its ...
April 2013
$ 2 000
Hyperglycemia - Pipeline Review, H1 2013 Summary Global Markets Direct's, 'Hyperglycemia - Pipeline Review, H2 2013', provides an overview of the indication's therapeutic pipeline. This report provides ...
April 2013
$ 2 000
This report provides data on the therapeutic development for Hyperphosphatemia, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved ...
March 2013
$ 2 000
This report provides data on the therapeutic development for Renal anemia, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved ...
April 2013
$ 1 500
H. Lundbeck A/S - Product Pipeline Review - 2013 Summary Global Market Direct's pharmaceuticals report, ?H. Lundbeck A/S - Product Pipeline Review - 2013? provides data on the H. Lundbeck A/S's research ...
April 2013
$ 1 500
Ltd. - Product Pipeline Review - H2 2011? provides a detailed overview on the Kyowa Hakko Kirin Co., Ltd.?s research and development focus. The report includes data on current developmental pipeline, ...
April 2013
$ 1 500
Bausch & Lomb Incorporated - Product Pipeline Review - 2013 Summary Global Market Direct's pharmaceuticals report, ?Bausch & Lomb Incorporated - Product Pipeline Review - 2013? provides data on the Bausch ...